- Demant revised its full-year organic revenue growth forecast to a range of 1% to 5%, down from a previous forecast of 3% to 7%.
- The company expects its earnings before interest and taxes (Ebit), excluding significant items, to be between DKK 4.10 billion and DKK 4.50 billion.
- Demant plans to continue its share buyback program, with purchases expected to exceed DKK 1.50 billion.
- First-quarter revenue reached DKK 5.62 billion, marking a year-over-year increase of 3.6%; however, organic revenue growth was flat at 0%.
- Demant has lowered its expectations for value growth in the global hearing aid market for 2025 to a range of 2% to 4%, compared to the previous expectation of 4% to 6%.
- The company cited macroeconomic uncertainties as a negative factor affecting the hearing aid market, particularly in the US, during the first quarter.
- Demant anticipates softer-than-normal market developments, compounded by recent exchange rate fluctuations.
- Current market analyst positions on Demant include 13 buy recommendations, 11 hold ratings, and 2 sell ratings.
A look at William Demant Holding A/S Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 1 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
William Demant Holding A/S, a company specializing in products aiding individuals with hearing loss, presents a mixed outlook based on the Smartkarma Smart Scores. While demonstrating moderate performance in growth, resilience, and momentum with scores of 3 in each category, the company lags in terms of value and dividend with scores of 2 and 1, respectively. This suggests a potential for growth and stability in the long term, yet investors may find the dividend aspect less appealing.
The Danish firm, Demant A/S, operates globally, focusing on the development, manufacture, and sale of innovative hearing devices, implants, diagnostic tools, and communication solutions for individuals with hearing impairments. As it strives to facilitate connectivity and effective communication for its diverse customer base worldwide, the company’s overall Smartkarma Smart Scores indicate a reasonably positive outlook despite variations in individual factors.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
